Literature DB >> 17940540

HIV-1 activates proinflammatory and interferon-inducible genes in human brain microvascular endothelial cells: putative mechanisms of blood-brain barrier dysfunction.

Anathbandhu Chaudhuri1, Fenghai Duan, Brenda Morsey, Yuri Persidsky, Georgette D Kanmogne.   

Abstract

The mechanisms underlying blood-brain barrier (BBB) dysfunction seen in human immunodeficiency virus 1 (HIV-1) infection are poorly understood; however, they are believed to be caused by interactions of human brain microvascular endothelial cells (HBMEC) with virus-infected macrophages. Using a transwell system and Affymetrix arrays, we investigated HIV-1-induced genomic changes in HBMEC after coculture with HIV-1-infected or -uninfected monocyte-derived macrophages (MDM). Differentially expressed genes were determined by linear modeling and then were grouped by hierarchical clustering. Compared to HBMEC cocultured with noninfected MDM, 184 probe sets corresponding to 84 genes were differentially expressed in HBMEC cocultured with HIV-infected MDM. Genes activated in HIV-1 MDM-exposed HBMEC included proinflammatory cytokines and chemokines, tumor necrosis factor-alpha-induced proteins, interferon (IFN)-inducible genes, intercellular adhesion molecule-1, transcription factors of the nuclear factor-kappaB family, and signal transducer and activator of transcription 1. Analysis of molecular networks and canonical pathways associated with differentially expressed genes suggest that HIV-1 causes BBB impairment by mechanisms involving inflammation, cytokine, and IFN signaling in HBMEC.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17940540     DOI: 10.1038/sj.jcbfm.9600567

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  40 in total

1.  The posterior reversible encephalopathy syndrome in HIV infection.

Authors:  Sam Nightingale; Chris Wood; Jonathan Ainsworth
Journal:  BMJ Case Rep       Date:  2012-06-25

2.  HIV-1 Tat and opioids act independently to limit antiretroviral brain concentrations and reduce blood-brain barrier integrity.

Authors:  Crystal R Leibrand; Jason J Paris; Austin M Jones; Quamrun N Masuda; Matthew S Halquist; Woong-Ki Kim; Pamela E Knapp; Angela D M Kashuba; Kurt F Hauser; MaryPeace McRae
Journal:  J Neurovirol       Date:  2019-05-17       Impact factor: 2.643

3.  In vitro models of molecular and nano-particle transport across the blood-brain barrier.

Authors:  Cynthia Hajal; Marco Campisi; Clara Mattu; Valeria Chiono; Roger D Kamm
Journal:  Biomicrofluidics       Date:  2018-05-31       Impact factor: 2.800

4.  Biodegradable polyanhydride-based nanomedicines for blood to brain drug delivery.

Authors:  Timothy M Brenza; Benjamin W Schlichtmann; Biju Bhargavan; Julia E Vela Ramirez; Rainie D Nelson; Matthew G Panthani; JoEllyn M McMillan; Balaraman Kalyanaraman; Howard E Gendelman; Vellareddy Anantharam; Anumantha G Kanthasamy; Surya K Mallapragada; Balaji Narasimhan; Georgette D Kanmogne
Journal:  J Biomed Mater Res A       Date:  2018-10-26       Impact factor: 4.396

5.  Exosomes contribute to the transmission of anti-HIV activity from TLR3-activated brain microvascular endothelial cells to macrophages.

Authors:  Li Sun; Xu Wang; Yu Zhou; Run-Hong Zhou; Wen-Zhe Ho; Jie-Liang Li
Journal:  Antiviral Res       Date:  2016-08-03       Impact factor: 5.970

6.  Toll-Like Receptor-3 Mediates HIV-1-Induced Interleukin-6 Expression in the Human Brain Endothelium via TAK1 and JNK Pathways: Implications for Viral Neuropathogenesis.

Authors:  Biju Bhargavan; Georgette D Kanmogne
Journal:  Mol Neurobiol       Date:  2017-11-11       Impact factor: 5.590

7.  Dysregulation of claudin-5 in HIV-induced interstitial pneumonitis and lung vascular injury. Protective role of peroxisome proliferator-activated receptor-γ.

Authors:  Hong Li; Sangya Singh; Raghava Potula; Yuri Persidsky; Georgette D Kanmogne
Journal:  Am J Respir Crit Care Med       Date:  2014-07-01       Impact factor: 21.405

8.  NanoART synthesis, characterization, uptake, release and toxicology for human monocyte-macrophage drug delivery.

Authors:  Ari S Nowacek; Reagan L Miller; Joellyn McMillan; Georgette Kanmogne; Michel Kanmogne; R Lee Mosley; Zhiya Ma; Sabine Graham; Mahesh Chaubal; Jane Werling; Barrett Rabinow; Huanyu Dou; Howard E Gendelman
Journal:  Nanomedicine (Lond)       Date:  2009-12       Impact factor: 5.307

Review 9.  Molecular mechanisms of neuroinvasion by monocytes-macrophages in HIV-1 infection.

Authors:  Gabriel Gras; Marcus Kaul
Journal:  Retrovirology       Date:  2010-04-07       Impact factor: 4.602

10.  STAT1 signaling modulates HIV-1-induced inflammatory responses and leukocyte transmigration across the blood-brain barrier.

Authors:  Anathbandhu Chaudhuri; Bo Yang; Howard E Gendelman; Yuri Persidsky; Georgette D Kanmogne
Journal:  Blood       Date:  2007-11-14       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.